T
GH icon

Tidemark’s Guardant Health GH Stock Holding History

Tidemark’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5K Hold
50
– – ﹤0.01% 544
2026
Q1 		$4.62K Hold
50
– – ﹤0.01% 562
2025
Q4 		$5.11K Hold
50
– – ﹤0.01% 499
2025
Q3 		$3.12K Hold
50
– – ﹤0.01% 569
2025
Q2 		$2.6K Hold
50
– – ﹤0.01% 587
2025
Q1 		$2.13K Hold
50
– – ﹤0.01% 612
2024
Q4 		$1.53K Sell
50
-15
-23% -$422 ﹤0.01% 605
2024
Q3 		$1.49K Buy
65
+50
+333% +$1.42K ﹤0.01% 564
2024
Q2 		$433 Sell
15
-191
-93% -$4.45K ﹤0.01% 594
2024
Q1 		$4.25K Sell
206
-88
-30% -$1.89K ﹤0.01% 530
2023
Q4 		$7.95K Buy
+294
New +$7.71K 0.01% 446

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Tidemark's GH Position: Q2 2026 in Review

Tidemark held its Guardant Health (GH) position steady in Q2 2026 at 50 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Tidemark first reported a position in GH in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.95K in Q4 2023. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Tidemark held 50 shares of Guardant Health worth $7.5K as of Q2 2026.
  • Tidemark left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #544 holding.
  • Tidemark first reported a position in Guardant Health in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Guardant Health position peaked at $7.95K in Q4 2023.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.